BindingDB logo
myBDB logout

56 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27894044 37 An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.EBI University of Kwazulu-Natal
18023192 2 Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.EBI Abx Advanced Biochemical Compounds
16250647 71 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.EBI Universit£
18851913 11 Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors.EBI Lund University
19469479 44 Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.EBI Universita Di Pisa
18651727 15 Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.EBI Johannes Gutenberg University
28606760 57 Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors.EBI Amgen
26950400 37 Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.BDB Tianjin University of Science and Technology
26398141 14 Evaluation of 2-indolcarbohydrazones as potent a-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.BDB Universiti Teknologi Mara (Uitm)
25511999 3 Design, Synthesis, and Biological Evaluation of Novel Benzoyl Diarylamine/ether Derivatives as Potential Anti-HIV-1 Agents.BDB Shandong University
26364932 22 Structure and Inhibition of Microbiome ß-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.BDB University of North Carolina At Chapel Hill
26158339 24 Type II Inhibitors Targeting CDK2.BDB University of Oxford